News and Events

ChemBridge to Attend and Exhibit at the CHI World Preclinical Congress in Boston, MA, USA, June 14-17, 2016

San Diego, CA, USA, March 21, 2016

The CHI World Preclinical Congress 2016 Conference and Exhibition will be held in Boston, MA, June 14-17, 2016. The World Preclinical Congress, produced and organized by CHI, is a dynamic conference for medicinal chemists working in pharma and biotech and is focused on discovery and optimization challenges of small molecule drug candidates. Concurrent meeting tracks include:

  • Novel Preclinical Models in Oncology
  • Cancer Immunotherapy and Combinations
  • New Approaches for Predicting Drug Toxicity
  • Advances in iPS Cell Technology for Drug Development Applications
  • Mastering Medicinal Chemistry
  • Blood-Brain Barrier
  • Tumor Models for Cancer Immunotherapy
  • Chemical Biology in Drug Discovery
  • Property-Based Drug Design in Medicinal Chemistry
  • Targeting Membrane Proteins

ChemBridge will be present to discuss our screening compound and building block offerings for small molecule drug discovery and chemical biology research including:

  • Our stock of more than 1.1 million small molecule screening compounds including sp3-enriched screening compounds with more 3- dimensional structure
  • Diversity libraries including the DIVERSet and PremiumSet Libraries
  • Targeted libraries and biased screening libraries for kinase, ion channel, GPCR, nuclear receptor and CNS research
  • Fragment Library compounds for fragment based drug discovery
  • Our stock of more than 14,000 building blocks / reagents for medicinal chemists

Please stop by the ChemBridge booth in the exhibit hall or contact Duncan Beniston, Executive Director Sales and Marketing, at duncan@chembridge.com to arrange a meeting.

back to top